TP53 and colorectal carcinoma: They found more than 1500 genes differentially expressed in CF patients, with enrichment for genes related to CRC, including CRC metastasis, tumor suppression, P53 (tumor protein 53), and the mTOR (mammalian target of rapamycin) pathway.